• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Myalgia (2238)
Event Type  Injury  
Event Description
This case was initially received via regulatory authority ((b)(6), reference number: (b)(4) on 11-mar-2022.This spontaneous case was reported by a consumer and describes the occurrence of myalgia ('muscle pain') in a (b)(6) female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.On (b)(6) 2015, the patient had essure inserted.On an unknown date, the patient experienced myalgia (seriousness criterion medically significant) and tendonitis ("tendinitis") and was found to have breath sounds abnormal ("murmur breathing").Essure treatment was not changed.At the time of the report, the myalgia, tendonitis and breath sounds abnormal outcome was unknown.The reporter provided no causality assessment for breath sounds abnormal, myalgia and tendonitis with essure.Diagnostic results (normal ranges are provided in parenthesis if available): body weight was reported to be (b)(6).Based on the available information, a review of our complaint records and other relevant data will be conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Manufacturer Narrative
This case was initially received via regulatory authority ansm, reference number: (b)(4) on 11-mar-2022.The most recent information was received on 17-mar-2022.This spontaneous case was reported by a consumer and describes the occurrence of myalgia ('muscle pain') in a 50-year-old female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.On (b)(6) 2015, the patient had essure inserted.On an unknown date, the patient experienced myalgia (seriousness criterion medically significant) and tendonitis ("tendinitis") and was found to have breath sounds abnormal ("murmur breathing").Essure treatment was not changed.At the time of the report, the myalgia, tendonitis and breath sounds abnormal outcome was unknown.The reporter provided no causality assessment for breath sounds abnormal, myalgia and tendonitis with essure.Diagnostic results (normal ranges are provided in parenthesis if available): body weight was reported to be 70 kgs.Quality-safety evaluation of ptc: no defect could be confirmed by the manufacturer.All product batches have met the specifications regarding labeling, material, and process controls at time of release.Trend analyses of complaints are reviewed regularly, no signal was observed with regard to the reported complaint reason.The risk management file was reviewed and an update was not deemed required.A technical investigation of the complaint sample and batch record review could not be conducted, as no sample or batch number were available.Most recent follow-up information incorporated above includes: on 17-mar-2022: quality safety evaluation of ptc based on the available information, a review of our complaint records and other relevant data was conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd, p.o. box 915
whippany, nj 
MDR Report Key13756925
MDR Text Key290545644
Report Number2951250-2022-00213
Device Sequence Number1
Product Code HHS
UDI-Device Identifier10888853003051
UDI-Public(01)10888853003051
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/14/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Is the Reporter a Health Professional? No
Date Manufacturer Received03/17/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age50 YR
Patient SexFemale
Patient Weight70 KG
-
-